PL2773205T3 - Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego - Google Patents
Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwegoInfo
- Publication number
- PL2773205T3 PL2773205T3 PL12844767.9T PL12844767T PL2773205T3 PL 2773205 T3 PL2773205 T3 PL 2773205T3 PL 12844767 T PL12844767 T PL 12844767T PL 2773205 T3 PL2773205 T3 PL 2773205T3
- Authority
- PL
- Poland
- Prior art keywords
- rifaximin
- retreating
- diarrhea
- bowel syndrome
- irritable bowel
- Prior art date
Links
- 208000002551 irritable bowel syndrome Diseases 0.000 title 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 title 1
- 229960003040 rifaximin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161554662P | 2011-11-02 | 2011-11-02 | |
| US201161559686P | 2011-11-14 | 2011-11-14 | |
| US201161560273P | 2011-11-15 | 2011-11-15 | |
| US201161560128P | 2011-11-15 | 2011-11-15 | |
| US201161560267P | 2011-11-15 | 2011-11-15 | |
| US201161560133P | 2011-11-15 | 2011-11-15 | |
| US201161560788P | 2011-11-16 | 2011-11-16 | |
| US201161563033P | 2011-11-22 | 2011-11-22 | |
| US201161564270P | 2011-11-28 | 2011-11-28 | |
| US201261600635P | 2012-02-18 | 2012-02-18 | |
| PCT/US2012/063380 WO2013067394A1 (en) | 2011-11-02 | 2012-11-02 | Methods for treating irritable bowel syndrome (ibs) and infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2773205T3 true PL2773205T3 (pl) | 2024-09-02 |
Family
ID=48192842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12844767.9T PL2773205T3 (pl) | 2011-11-02 | 2012-11-02 | Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20130184302A1 (pl) |
| EP (1) | EP2773205B1 (pl) |
| JP (1) | JP2014532723A (pl) |
| AU (1) | AU2012332211B2 (pl) |
| CA (1) | CA2854380A1 (pl) |
| ES (1) | ES2986825T3 (pl) |
| PL (1) | PL2773205T3 (pl) |
| WO (1) | WO2013067394A1 (pl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1698630E (pt) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais |
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| EP3140313B1 (en) | 2014-05-04 | 2020-02-26 | Salix Pharmaceuticals, Inc. | Ibs microbiota and uses thereof |
| WO2016003536A1 (en) * | 2014-06-30 | 2016-01-07 | Salix Pharmaceuticals, Inc. | Methods for retreating irritable bowel syndrome (ibs) |
| EA039096B1 (ru) * | 2014-08-11 | 2021-12-03 | Саликс Фармасьютикалз, ИНК. | Способы лечения заболевания кишечника (срк) |
| US10789334B2 (en) | 2014-10-21 | 2020-09-29 | Psomagen, Inc. | Method and system for microbial pharmacogenomics |
| US10409955B2 (en) | 2014-10-21 | 2019-09-10 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions |
| US9754080B2 (en) | 2014-10-21 | 2017-09-05 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions |
| US10777320B2 (en) | 2014-10-21 | 2020-09-15 | Psomagen, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions |
| US10366793B2 (en) | 2014-10-21 | 2019-07-30 | uBiome, Inc. | Method and system for characterizing microorganism-related conditions |
| US10388407B2 (en) | 2014-10-21 | 2019-08-20 | uBiome, Inc. | Method and system for characterizing a headache-related condition |
| US10395777B2 (en) | 2014-10-21 | 2019-08-27 | uBiome, Inc. | Method and system for characterizing microorganism-associated sleep-related conditions |
| US10169541B2 (en) | 2014-10-21 | 2019-01-01 | uBiome, Inc. | Method and systems for characterizing skin related conditions |
| US10325685B2 (en) | 2014-10-21 | 2019-06-18 | uBiome, Inc. | Method and system for characterizing diet-related conditions |
| US10410749B2 (en) | 2014-10-21 | 2019-09-10 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions |
| US11783914B2 (en) | 2014-10-21 | 2023-10-10 | Psomagen, Inc. | Method and system for panel characterizations |
| US10793907B2 (en) | 2014-10-21 | 2020-10-06 | Psomagen, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions |
| US10073952B2 (en) | 2014-10-21 | 2018-09-11 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions |
| US10357157B2 (en) | 2014-10-21 | 2019-07-23 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features |
| US10311973B2 (en) | 2014-10-21 | 2019-06-04 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions |
| US9760676B2 (en) | 2014-10-21 | 2017-09-12 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions |
| US9758839B2 (en) | 2014-10-21 | 2017-09-12 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features |
| US9703929B2 (en) | 2014-10-21 | 2017-07-11 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
| US10381112B2 (en) | 2014-10-21 | 2019-08-13 | uBiome, Inc. | Method and system for characterizing allergy-related conditions associated with microorganisms |
| US10265009B2 (en) | 2014-10-21 | 2019-04-23 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features |
| US10346592B2 (en) | 2014-10-21 | 2019-07-09 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues |
| US9710606B2 (en) | 2014-10-21 | 2017-07-18 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues |
| CN104586855A (zh) * | 2014-12-29 | 2015-05-06 | 天津市中升挑战生物科技有限公司 | 一种复方利福昔明子宫注入剂及其制备方法与应用 |
| US10246753B2 (en) | 2015-04-13 | 2019-04-02 | uBiome, Inc. | Method and system for characterizing mouth-associated conditions |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
| IT1199374B (it) | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
| US7902206B2 (en) | 2003-11-07 | 2011-03-08 | Alfa Wassermann, S.P.A. | Polymorphic forms α, β and γ of rifaximin |
| ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
| PT1698630E (pt) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais |
| WO2007101161A2 (en) * | 2006-02-24 | 2007-09-07 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| KR101480732B1 (ko) * | 2006-09-22 | 2015-01-21 | 씨아이피엘에이 엘티디. | 리팍시민 |
| US8383151B2 (en) | 2007-07-06 | 2013-02-26 | Lupin Limited | Pharmaceutical compositions of rifaximin |
| US7709634B2 (en) | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
| US8486956B2 (en) | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
| SG10201607926VA (en) * | 2008-02-25 | 2016-11-29 | Salix Pharmaceuticals Ltd | Forms of rifaximin and uses thereof |
| ES2727728T3 (es) | 2008-02-26 | 2019-10-18 | Salix Pharmaceuticals Ltd | Métodos para el tratamiento del síndrome del intestino irritable |
| EP2350096B1 (en) * | 2008-10-02 | 2019-12-11 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
| EP2437603A4 (en) | 2009-06-02 | 2012-12-12 | Salix Pharmaceuticals Ltd | METHODS OF TREATING HEPATIC ENCEPHALOPATHY |
| CA2773982C (en) * | 2009-09-13 | 2018-12-04 | Salix Pharmaceuticals, Ltd. | Methods for treating irritable bowel syndrome (ibs) |
| EP2504457A4 (en) * | 2009-11-25 | 2013-08-14 | Nestec Sa | NOVEL GENOMIC BIOMARKERS USED IN THE DIAGNOSIS OF IRRITABLE COLON SYNDROME |
| EP2536282A4 (en) * | 2010-02-18 | 2013-07-03 | Salix Pharmaceuticals Ltd | METHOD FOR THE TREATMENT OF INFECTIONS |
| NZ603590A (en) | 2010-06-03 | 2015-08-28 | Salix Pharmaceuticals Ltd | New forms of rifaximin and uses thereof |
| EP3750526A1 (en) * | 2010-07-12 | 2020-12-16 | Salix Pharmaceuticals, Inc. | Formulations of rifaximin and uses thereof |
| AU2012214239B2 (en) | 2011-02-11 | 2016-06-30 | Salix Pharmaceuticals, Ltd. | Forms of Rifaximin and uses thereof |
| KR102284565B1 (ko) | 2017-07-31 | 2021-07-30 | 에스지 디제이아이 테크놀러지 코., 엘티디 | 포인트 클라우드에서의 모션 기반 부정확성의 정정 |
| US11960008B2 (en) | 2018-05-17 | 2024-04-16 | Cmos Sensor, Inc. | Method and system for pseudo 3D mapping in robotic applications |
| KR102382079B1 (ko) | 2020-02-11 | 2022-03-31 | 효성중공업 주식회사 | 에어갭 조절장치 |
| US11963008B2 (en) | 2020-11-25 | 2024-04-16 | Truist Bank | Geolocation-based notifications using relationships in separate systems |
-
2012
- 2012-11-02 ES ES12844767T patent/ES2986825T3/es active Active
- 2012-11-02 CA CA2854380A patent/CA2854380A1/en not_active Abandoned
- 2012-11-02 EP EP12844767.9A patent/EP2773205B1/en active Active
- 2012-11-02 AU AU2012332211A patent/AU2012332211B2/en active Active
- 2012-11-02 JP JP2014540145A patent/JP2014532723A/ja active Pending
- 2012-11-02 PL PL12844767.9T patent/PL2773205T3/pl unknown
- 2012-11-02 US US13/667,585 patent/US20130184302A1/en not_active Abandoned
- 2012-11-02 WO PCT/US2012/063380 patent/WO2013067394A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2773205B1 (en) | 2024-05-22 |
| EP2773205A4 (en) | 2015-03-25 |
| WO2013067394A1 (en) | 2013-05-10 |
| CA2854380A1 (en) | 2013-05-10 |
| US20130184302A1 (en) | 2013-07-18 |
| JP2014532723A (ja) | 2014-12-08 |
| AU2012332211A1 (en) | 2014-05-22 |
| EP2773205A1 (en) | 2014-09-10 |
| ES2986825T3 (es) | 2024-11-12 |
| HK1200276A1 (en) | 2015-08-07 |
| AU2012332211B2 (en) | 2016-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2773205T3 (pl) | Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego | |
| ZA201401577B (en) | New bicyclic dihydroquinoline-2-one derivatives | |
| IL232570A0 (en) | Bicyclic derivatives of dihydroisoquinoline-1-one | |
| GB201106799D0 (en) | Novel compounds | |
| GB201107325D0 (en) | Novel compounds | |
| GB201120340D0 (en) | Automotive glazing | |
| ZA201309411B (en) | Anti-thrombotic compounds | |
| ZA201306397B (en) | Capping chuck assembly | |
| EP2709609A4 (en) | HETEROCYCLIC COMPOUNDS | |
| EP2703394A4 (en) | NEW 3-HYDROXYISOTHIAZOLE 1-OXIDE DERIVATIVE | |
| EP2670746A4 (en) | BICYCLIC HETEROARYL COMPOUNDS AS GPR119 RECEPTOR AGONISTS | |
| GB2495154B (en) | Damped self-centering hinge | |
| EP2717694A4 (en) | NEW COMPOUNDS | |
| EP2797928A4 (en) | NEW ORGANIC COMPOUND | |
| ZA201403513B (en) | Bicyclic heterocyclic compound | |
| GB2490023B (en) | Broken pipe blocker | |
| GB2512751B (en) | Damped self-centering hinge | |
| IL212441A0 (en) | Centrifuge | |
| GB201106801D0 (en) | Novel compounds | |
| GB201101640D0 (en) | Novel compounds | |
| GB201103073D0 (en) | Novel compounds | |
| GB201103283D0 (en) | Novel compounds | |
| GB201101085D0 (en) | Novel compounds | |
| GB201104138D0 (en) | Novel compounds | |
| GB201109508D0 (en) | Novel compounds |